Back to Search
DON MCNEEL, MD
MD
Family Medicine Physician
NPI: 1609860394IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
10164(NH)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
10164(NH)24175(SC)
CMS Specialties
PrimaryFAMILY PRACTICE
Additional
PERIPHERAL VASCULAR DISEASE
Education
UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
PMID 19636017·J Clin Oncol·2009
3-trial
Prostate cancer antigens and vaccines, preclinical developments.
PMID 16110615·Cancer Chemother Biol Response Modif·2005
6-review
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.
PMID 16278408·Clin Cancer Res·2005
3-trial
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant.
PMID 12645861·J Clin Immunol·2003
3-trial
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer.
PMID 11025777·J Urol·2000
8-other
An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.
PMID 19603556·J Clin Invest·2009
7-preclinical
Methods for constructing and evaluating antitumor DNA vaccines.
PMID 19565905·Methods Mol Biol·2009
7-preclinical
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
PMID 19401350·Clin Cancer Res·2009
8-other
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.
PMID 19147575·Cancer Res·2009
3-trial
His-tag ELISA for the detection of humoral tumor-specific immunity.
PMID 18510754·BMC Immunol·2008
4-observational
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.
PMID 18451239·Clin Cancer Res·2008
3-trial
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.
PMID 18413835·Clin Cancer Res·2008
3-trial
Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer.
PMID 17879963·Prostate·2007
8-other
GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer.
PMID 18034654·Expert Opin Biol Ther·2007
6-review
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
PMID 17929270·Prostate·2007
8-other
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
PMID 17893560·J Immunother·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11402 ANDERSON RD STE B
GREENVILLE, SC 29611 - Phone
- (864) 631-2799
Quick Facts
- NPI
- 1609860394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile